AMRN
Amarin Corporation plc$15.21+0.31 (+2.06%)Prev Close$14.90·MCap$301.6M·P/E—·Vol66.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
9
$796.8K
◆
Net Activity
Net Seller
$796.8K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Amarin Corporation plc (AMRN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $796.8K. The most recent insider transaction was by Berg Aaron (President and CEO), who sold $35.4K worth of shares on Jan 31, 2026. Amarin Corporation plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $301.6M.
AMRN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Berg Aaron | President and CEO | Sell | 2,298 | $15.42 | $35.4K | 0 |
| Jan 31, 2026 | Fishman Peter L. | SVP, CFO | Sell | 1,318 | $15.42 | $20.3K | 0 |
| Jan 31, 2026 | Keenan David Paul | EVP, Chief Operating Officer | Sell | 2,183 | $15.42 | $33.7K | 0 |
| Jan 2, 2026 | Fishman Peter L. | SVP, CFO | Sell | 1,356 | $13.96 | $18.9K | 0 |
| Jan 2, 2026 | Keenan David Paul | EVP, Chief Operating Officer | Sell | 1,926 | $13.96 | $26.9K | 0 |
| Jan 2, 2026 | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 2,041 | $13.96 | $28.5K | 0 |
| Jan 2, 2026 | Provoost Jonathan | EVP, Chief Legal Officer | Sell | 1,488 | $13.96 | $20.8K | 0 |
| Aug 1, 2025 | Fishman Peter L. | SVP, CFO | Sell | 160 | $14.52 | $2.3K | 0 |
| Jun 26, 2025 | Berg Aaron | President and CEO | Sell | 38,363 | $15.90 | $610.0K | 0 |
| Apr 18, 2025 | Cohen Paul | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Mar 1, 2025 | Fishman Peter L. | SVP, CFO | Sell | 1,748 | $0.64 | $1.1K | 0 |
| Jan 31, 2025 | Fishman Peter L. | SVP, CFO | Sell | 31,112 | $0.62 | $19.3K | 0 |
| Jan 30, 2025 | Ketchum Steven B | Chief Scientific Officer | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Aug 2, 2024 | Berg Aaron | President and CEO | Buy | 160,000 | $0.64 | $102.4K0.8% OS | 0 |
| Jul 1, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 8,209 | $0.69 | $5.7K | 0 |
| Jun 20, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 16,417 | $0.73 | $12.0K | 0 |
| Jan 31, 2024 | Berg Aaron | EVP, President US | Sell | 40,822 | $1.24 | $50.6K | 0 |
| Jan 31, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 41,187 | $1.24 | $51.1K | 0 |
| Jan 31, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 24,552 | $1.24 | $30.4K | 0 |
| Jan 22, 2024 | Holt Patrick | President and CEO | Buy | 14,426 | $1.09 | $15.7K | 0 |
| Jan 10, 2024 | Berg Aaron | EVP, President US | Sell | 28,214 | $0.97 | $27.4K | 0 |
| Jan 10, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 28,270 | $0.97 | $27.4K | 0 |
| Jan 10, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 28,325 | $0.97 | $27.5K | 0 |
| Jan 4, 2024 | Berg Aaron | EVP, President US | Sell | 15,460 | $0.87 | $13.5K | 0 |
| Jan 4, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 7,730 | $0.87 | $6.7K | 0 |
| Dec 29, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 12, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 34,131 | $0.79 | $27.0K | 0 |
| Aug 16, 2023 | Holt Patrick | President and CEO | Buy | 300,000 | $1.04 | $312.3K1.5% OS | 0 |
| Jul 31, 2023 | Berg Aaron | EVP, President US | Sell | 11,763 | $1.19 | $14.0K | 0 |
| Jul 31, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 11,763 | $0.78 | $9.2K | 0 |
| Jun 20, 2023 | Reilly Thomas Charles | SVP and CFO | Sell | 24,626 | $1.19 | $29.3K | 0 |
| Feb 28, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Jan 31, 2023 | Berg Aaron | EVP, President US | Sell | 41,869 | $1.82 | $76.2K | 0 |
| Jan 31, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 28,226 | $1.83 | $51.6K | 0 |
| Jan 31, 2023 | Mikhail Karim | President and CEO | Sell | 72,311 | $1.85 | $133.9K | 0 |
| Dec 30, 2022 | Berg Aaron | EVP, President US | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022 | Mikhail Karim | President and CEO | Sell | 1,270 | $1.21 | $1.5K | 0 |
| Aug 19, 2022 | Marks Jason M. | EVP,Chief Global Legal Officer | Sell | 11,417 | $1.60 | $18.3K | 0 |
| Jul 29, 2022 | Berg Aaron | EVP, President US | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 29, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 46,902 | $1.33 | $62.4K | 0 |
| Jul 1, 2022 | Mikhail Karim | President and CEO | Sell | 10,780 | $1.49 | $16.1K | 0 |
| Jun 13, 2022 | WOLD OLSEN PER | Director | Buy | 55,000 | $1.69 | $92.7K | 0 |
| Apr 12, 2022 | Mikhail Karim | President and CEO | Sell | 20,631 | $3.35 | $69.1K | 0 |
| Feb 28, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 6,213 | $3.27 | $20.3K | 0 |
| Feb 28, 2022 | Ketchum Steven B | Chief Scientific Officer | Sell | 5,508 | $3.27 | $18.0K | 0 |
| Jan 31, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 5,317 | $3.36 | $17.9K | 0 |
| Jan 31, 2022 | Ketchum Steven B | Chief Scientific Officer | Sell | 5,121 | $3.36 | $17.2K | 0 |
| Dec 31, 2021 | Kalb Michael Wayne | SVP and CFO | Sell | 25,379 | $3.35 | $85.0K | 0 |
| Dec 31, 2021 | Ketchum Steven B | Chief Scientific Officer | Sell | 24,433 | $3.35 | $81.9K | 0 |
| Dec 31, 2021 | Mikhail Karim | President and CEO | Sell | 3,876 | $3.35 | $13.0K | 0 |
Showing 1–50 of 83
1 / 2
AMRN Insider Buying Activity
The following table shows recent insider purchases of Amarin Corporation plc (AMRN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | Berg Aaron | President and CEO | Buy | 160,000 | $0.64 | $102.4K0.8% OS | 0 |
| Jan 22, 2024 | Holt Patrick | President and CEO | Buy | 14,426 | $1.09 | $15.7K | 0 |
| Aug 16, 2023 | Holt Patrick | President and CEO | Buy | 300,000 | $1.04 | $312.3K1.5% OS | 0 |
| Jun 13, 2022 | WOLD OLSEN PER | Director | Buy | 55,000 | $1.69 | $92.7K | 0 |
AMRN Insider Selling Activity
The following table shows recent insider sales of Amarin Corporation plc (AMRN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Berg Aaron | President and CEO | Sell | 2,298 | $15.42 | $35.4K | 0 |
| Jan 31, 2026 | Fishman Peter L. | SVP, CFO | Sell | 1,318 | $15.42 | $20.3K | 0 |
| Jan 31, 2026 | Keenan David Paul | EVP, Chief Operating Officer | Sell | 2,183 | $15.42 | $33.7K | 0 |
| Jan 2, 2026 | Fishman Peter L. | SVP, CFO | Sell | 1,356 | $13.96 | $18.9K | 0 |
| Jan 2, 2026 | Keenan David Paul | EVP, Chief Operating Officer | Sell | 1,926 | $13.96 | $26.9K | 0 |
| Jan 2, 2026 | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 2,041 | $13.96 | $28.5K | 0 |
| Jan 2, 2026 | Provoost Jonathan | EVP, Chief Legal Officer | Sell | 1,488 | $13.96 | $20.8K | 0 |
| Aug 1, 2025 | Fishman Peter L. | SVP, CFO | Sell | 160 | $14.52 | $2.3K | 0 |
| Jun 26, 2025 | Berg Aaron | President and CEO | Sell | 38,363 | $15.90 | $610.0K | 0 |
| Apr 18, 2025 | Cohen Paul | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Mar 1, 2025 | Fishman Peter L. | SVP, CFO | Sell | 1,748 | $0.64 | $1.1K | 0 |
| Jan 31, 2025 | Fishman Peter L. | SVP, CFO | Sell | 31,112 | $0.62 | $19.3K | 0 |
| Jan 30, 2025 | Ketchum Steven B | Chief Scientific Officer | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Jul 1, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 8,209 | $0.69 | $5.7K | 0 |
| Jun 20, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 16,417 | $0.73 | $12.0K | 0 |
| Jan 31, 2024 | Berg Aaron | EVP, President US | Sell | 40,822 | $1.24 | $50.6K | 0 |
| Jan 31, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 41,187 | $1.24 | $51.1K | 0 |
| Jan 31, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 24,552 | $1.24 | $30.4K | 0 |
| Jan 10, 2024 | Berg Aaron | EVP, President US | Sell | 28,214 | $0.97 | $27.4K | 0 |
| Jan 10, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 28,270 | $0.97 | $27.4K | 0 |
| Jan 10, 2024 | Reilly Thomas Charles | EVP and CFO | Sell | 28,325 | $0.97 | $27.5K | 0 |
| Jan 4, 2024 | Berg Aaron | EVP, President US | Sell | 15,460 | $0.87 | $13.5K | 0 |
| Jan 4, 2024 | Ketchum Steven B | Chief Scientific Officer | Sell | 7,730 | $0.87 | $6.7K | 0 |
| Dec 29, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 12, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 34,131 | $0.79 | $27.0K | 0 |
| Jul 31, 2023 | Berg Aaron | EVP, President US | Sell | 11,763 | $1.19 | $14.0K | 0 |
| Jul 31, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 11,763 | $0.78 | $9.2K | 0 |
| Jun 20, 2023 | Reilly Thomas Charles | SVP and CFO | Sell | 24,626 | $1.19 | $29.3K | 0 |
| Feb 28, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Jan 31, 2023 | Berg Aaron | EVP, President US | Sell | 41,869 | $1.82 | $76.2K | 0 |
| Jan 31, 2023 | Ketchum Steven B | Chief Scientific Officer | Sell | 28,226 | $1.83 | $51.6K | 0 |
| Jan 31, 2023 | Mikhail Karim | President and CEO | Sell | 72,311 | $1.85 | $133.9K | 0 |
| Dec 30, 2022 | Berg Aaron | EVP, President US | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022 | Mikhail Karim | President and CEO | Sell | 1,270 | $1.21 | $1.5K | 0 |
| Aug 19, 2022 | Marks Jason M. | EVP,Chief Global Legal Officer | Sell | 11,417 | $1.60 | $18.3K | 0 |
| Jul 29, 2022 | Berg Aaron | EVP, President US | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 29, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 46,902 | $1.33 | $62.4K | 0 |
| Jul 1, 2022 | Mikhail Karim | President and CEO | Sell | 10,780 | $1.49 | $16.1K | 0 |
| Apr 12, 2022 | Mikhail Karim | President and CEO | Sell | 20,631 | $3.35 | $69.1K | 0 |
| Feb 28, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 6,213 | $3.27 | $20.3K | 0 |
| Feb 28, 2022 | Ketchum Steven B | Chief Scientific Officer | Sell | 5,508 | $3.27 | $18.0K | 0 |
| Jan 31, 2022 | Kalb Michael Wayne | SVP and CFO | Sell | 5,317 | $3.36 | $17.9K | 0 |
| Jan 31, 2022 | Ketchum Steven B | Chief Scientific Officer | Sell | 5,121 | $3.36 | $17.2K | 0 |
| Dec 31, 2021 | Kalb Michael Wayne | SVP and CFO | Sell | 25,379 | $3.35 | $85.0K | 0 |
| Dec 31, 2021 | Ketchum Steven B | Chief Scientific Officer | Sell | 24,433 | $3.35 | $81.9K | 0 |
| Dec 31, 2021 | Mikhail Karim | President and CEO | Sell | 3,876 | $3.35 | $13.0K | 0 |
AMRN Insiders
Similar Stocks to AMRN
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B